MICHAEL R DOUGHERTY
CIK 1033516 · Executive Chairman · last filed 2023-06-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$32.48M
Companies
10
Total Filings
80
Lifetime Open-Market Net
-$118.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRVN | Director | 7,000 | $0.01 | $78 | $28.0K | 10 | 2023-06-20 |
| Aceragen, Inc. (IDRA) Delisted | Director | 375,155 | $7.22 | $2.71M | $101.2K | 19 | 2023-01-12 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 3,312 | $0.55 | $1.8K | $0 | 5 | 2022-02-07 |
| Foundation Medicine, Inc. (FMI) Delisted | Director | 24,789 | — | — | $0 | 2 | 2017-06-22 |
| AVIR | Director | — | $4.49 | — | $0 | 2 | 2017-05-22 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Director | 2,000 | — | — | $36.9K | 6 | 2017-01-05 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | Executive Chairman | 0 | — | — | $42.9K | 6 | 2016-07-12 |
| Vaxart, Inc. (BOTA) Delisted | Director | — | — | — | $0 | 3 | 2015-08-13 |
| VIROPHARMA INC (VPHM) Delisted | Director | 21,500 | — | — | -$511.6K | 10 | 2013-12-20 |
| RPRX | President & CEO | 591,911 | $54.87 | $32.48M | $184.4K | 11 | 2010-09-13 |
Recent Filings · Page 5 of 8
80 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-05 | MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-27 | MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Buy (P) | +2,000 | $36.9K | EDGAR |
| 2015-08-24 | Celator Pharmaceuticals Inc (CPXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-13 | Vaxart, Inc. (BOTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-15 | Celator Pharmaceuticals Inc (CPXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-21 | TRVN | Grant (A) | — | $0 | EDGAR |
| 2015-05-14 | Vaxart, Inc. (BOTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-02 | MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-10 | TRVN | Buy (P) | +7,000 | $28.0K | EDGAR |
| 2014-11-20 | Celator Pharmaceuticals Inc (CPXX) Delisted | Buy (P) | +20,000 | $42.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.